Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.
Thomas Luft1, Sascha Dietrich, Christine Falk
1Department of Medicine V, University of Heidelberg, Heidelberg, Germany;
Blood
|June 4, 2011
Summary
Acute graft-versus-host disease (GVHD) refractory to steroids suggests endothelial damage, not T-cell attack. Elevated angiopoietin-2 (ANG2) indicates endothelial dysfunction drives treatment resistance in GVHD.
Area of Science:
- Hematology
- Immunology
- Transplantation
Background:
- Acute graft-versus-host disease (GVHD) is a significant complication following allogeneic stem cell transplantation (SCT).
- While many patients respond to high-dose steroids, refractory GVHD carries a poor prognosis and suggests alternative pathomechanisms.
- End-organ damage in refractory GVHD indicates processes beyond the initial T-cell mediated attack.
Purpose of the Study:
- To investigate the role of endothelial damage in steroid-refractory acute GVHD.
- To explore the involvement of angiopoietin-2 (ANG2) in GVHD refractoriness.
- To compare immune and endothelial dysfunction markers in sensitive versus refractory GVHD.
Main Methods:
- Compared T-cell activation markers and endothelial dysfunction markers in patients with sensitive (n=23) and refractory (n=25) GVHD.
- Utilized longitudinal serum measurements, including soluble FAS ligand, thrombomodulin, ANG2, and vascular endothelial-derived growth factor (VEGF).
- Analyzed marker kinetics in relation to GVHD sensitivity and treatment refractoriness.
Main Results:
- Refractory GVHD patients did not show evidence of overwhelming or unresponsive T-cell attacks.
- Rising thrombomodulin levels and high ANG2/VEGF ratios were associated with refractory GVHD.
- Patients with refractory GVHD exhibited elevated ANG2 levels prior to SCT.
Conclusions:
- Endothelial cell vulnerability and dysfunction, rather than T-cell activity, appear to drive treatment refractoriness in acute GVHD.
- These findings suggest novel biomarkers for predicting and managing refractory GVHD.
- Targeting endothelial pathways may offer new therapeutic strategies for refractory GVHD.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...